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ABSTRACT
Introduction. Neurological postsurgical complications are a significant cause of morbid-
ity and mortality occur in transplant recipients impacting their survival.
Methods. We analyzed the medical records of 269 patients who underwent transplan-
tation between 2000 and 2011, after application of the exclusion criteria Neurological
complications were examined according to the period in which they appeared: immediate
(1–30 day) early (31–180 days), and late (after 180 days). The survival analysis was based
on the first complication.
Results. The majority of transplant recipients were males (73.2%) and white (97.1%)
with an overall median age of 49 (range, 18–73) years. Regarding the etiology for
transplantation, the most common causes were hepatitis C virus (56.5%) and alcohol
(33.1%). Complications, appearing in 29.4% (immediate), 31.5% (early), and 39.1% (late)
cases, were encephalopathy, confusion, tremors, headache, and stroke. Patients who had
the first complication between 1 and 6 months showed greater mortality than those who
had one after 6 months.
Conclusions. Neurological complications led to longer hospital stays with greater early
morbidity and mortality. Knowledge of these complications appears to be extremely
important for the multidisciplinary transplantation team to decrease its prevalence as well
as to diagnose and treat early.ORTHOTOPIC liver transplantation (OLT), launchedin 1963 by Thomas Starzl, shows satisfactory out-
omes in patients with end-stage liver disease.1 Surgical
echniques have evolved and new immunosuppressive drugs
pplied to achieve improving outcomes.2,3
Posttransplantation complications can result from pre-
transplantation, factors such as alcoholism, hepatitis C virus
infection, and malnutrition, as well as intraoperative and
postoperative factors, including immunosuppressive drug
treatment or infections. Among the complications that
occur within 30 days after transplantation, immediate neu-
rological problems have third increased to the major
course.3,4 These complications present a significant risk of
orbidity and mortality,4 significantly impacting recovery
and quality of life. Subjects who suffer neurological compli-
cations (NC) are hospitalized longer, contract more infec-
tions, and accordingly show lower self-sufficiency and social
reintegration.3–7 The aim of this study was to determine the
ccurrence of such complications in transplant recipients
nd their survival.
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1126METHODS
This observational, cross-sectional, retrospective study included
evaluations of liver transplantation patient records operated be-
tween July 2000 and June 2011. We excluded subjects with fulmi-
nant hepatic failure, retransplantations, reduced grafts, children,
deaths within 48 hours, and cases with incomplete information, 269
for analysis among 338 total patients.
The following data were collected: gender, age (years at trans-
plantation), race (white versus nonwhite), etiology of liver disease,
NC and when they appeared, hospitalization length, causes of
mortality, and immunosuppression.
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NEUROLOGICAL COMPLICATIONS 1127Evaluation of the collected data was performed for weekly
intervals during the first month (immediate NC, 1– days); monthly
from the second to sixth month (early NC, 31–180 days), and,
finally, 6 months after surgery (late NC, after 180 days).
NC were considered when diagnosed by clinical and/or radiolog-
ical tests computed tomography [CT] and magnetic resonance
imaging [MRI] but not associated with sepsis, graft dysfunction, or
other diseases that might cause signs and symptoms in the nervous
system. Clinical examinations were made by the staff of the
intensive care unit (ICU) and the liver transplantation team under
the supervision of neurologists.
The NC were classified as minor (confusion, tremor, sleep
disorders, peripheral neuropathy, and headache) or major (en-
cephalopathy, seizures, cerebrovascular accident [CVA], and veg-
etative state).3
Data were analyzed using STATISTICA 11.0 (StatSoft, NY,
United States). We used descriptive statistics for continuous vari-
ables and the Kaplan-Meier method to examine the survival rate
applying a log-rank test with P  .05 to assess significant differ-
ences.
RESULTS
Among transplanted men (73.2%) there was a predomi-
nance of the fourth and fifth decades of life. Regarding
ethnicity, 261 white patients underwent transplantation
(97.0%); 8 subjects were nonwhite (3.0%). The mean
hospital stay after surgery was 19 days (range, 6–87) among
patients with some NC versus 16 days (range, 7–53) among
those free of these problems. The etiology requiring trans-
plantation was hepatitis C virus (n  152; 56.5%), alcohol
n  89 cases; 33.1%), hepatocellular carcinoma (n  82;
0.5%), and hepatitis B (n  22; 8.2%).
The NC classification of 258 instances showed 203 minor
nd 55 major complications. The number of patients with
mmediates NC was 79/269 (29.4%) who experienced 86
eported NC 7 patients had 2 complications). Among the
arly NC group, we observed 73/232 (31.5%) with 92 NC.
fter 180 postoperative days, we observed 80 NC in 79/202
39.1%) patients (Table 1).
Examination of long-term survival after 10 years showed
hat patients who experienced a NC after postoperative day
80 showed better survival than those who displayed one in
he immediate or early period (Fig 1).
Table 1. Distribution of NC According
Complication 1st Week 2nd Week
Major (n  55)
Seizures 7 (2.7%) 0
Vegetative state 1 (0.4%) 0
Encephalopathy 8 (3.1%) 4 (1.5%)
CVA 4 (1.5%) 1 (0.4%)
Minor (n  203)
Tremor 0 4 (1.5%)
Sleep disorder 0 2 (0.8%)
Neuropathy 0 0
Mental confusion 9 (3.4%) 9 (3.4%)
Headache 0 0 2 (0.8DISCUSSION
Regarding the immediate period, 79 (28.4%) patients
showed 86 NC, 34.9% of which were major. The data
confirmed the conclusions of many authors that NC in the
first month after surgery, since the percentage ranges from
10%–47%, being a very common consensus in a third.3,4,7–9
As also previously described, the number of complications
was higher in the first week, in addition to being the most
severe. Therefore, the number of major NC significantly
decreased from 20 in the first week, 5 in the second, 3 in the
third, and 2 in the fourth week.
Encephalopathy in the immediate period accounted for
13.9% of cases; within the literature the range is 11.8%–
48%.3,10 Among all NC, it was the third most common, being
he first among the major problems. Patients had a diversified,
linical picture, which included apathy, delusions, agitation,
onfusion of thoughts, and repeating of illogical sentences.
ue to its various etiologies, it was difficult to highlight just
ne factor, eg, neurotoxicity of immunosuppressants, osmotic
r electrolyte disorders, or infections.3
Seizures represented 12.8% of the NC in the immediate
period, it compatible with the already described variation
from 0%–40%.3,5,6,8–10 It was the fourth most common NC
and the second among the major problems. However, the
literature shows it to be the second most common prob-
lem.2 As described, the crises were preceded by a clinical
ncephalopathy. Most cases were related to central nervous
ystem (CNS) lesions, such as occur after infections, neu-
otoxicity of immunosuppressants, and osmotic disorders.
VA represented 7.0% of immediate NC, also within the
eported 2.0%–13.0% range.1,9 Some patients had more
than 1 event, increasing the mortality and the incapacity
after the complications. Ischemic and hemorrhagic events
occurred in the same proportion. And finally, among the
major NC, only 1 patient displayed a vegetative state
(1.2%), being the NC least common in the immediate
period.
During the immediate period, confusion especially for
minor NC was most prevalent, accounting for 26.7% of
cases, which is consistent with the literature rates of 17.4%–
27.3%.1,8,10 This rich clinical spectrum included confusion
f thoughts, dizziness, memory failures, disorientation, and
stoperative Period (n  258 Patients)
eek 4th Week 31–180 Days 180 Days
%) 1 (0.4%) 2 (0.8%) 2 (0.8%)
0 0 0
0 7 (2.7%) 6 (2.3%)
1 (0.4%) 4 (1.5%) 3 (1.1%)
%) 7 (2.7%) 18 (7.0%) 9 (3.4%)
%) 4 (1.5%) 8 (3.1%) 7 (2.7%)
%) 3 (1.1%) 18 (7.0%) 7 (2.7%)
%) 1 (0.4%) 15 (5.8%) 17 (6.6%)to Po
3rd W
3 (1.1
0
0
0
2 (0.8
2 (0.8
4 (1.5
4 (1.5%) 3 (1.1%) 20 (7.7%) 28 (10.8%)
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1128 COLOMBARI, DE ATAÍDE, UDO ET ALcrying jags that were often related to the toxic effects of
immunosuppressants, infections, and electrolyte distur-
bances. Tremors were the second most common (15.1%,
literature varies from 9.0%–18%).5,8 Most were fine trem-
ors of the extremities related to the neurotoxicity of immu-
nosuppressive drugs. After dose adjustment, they decreased
or ceased. Sleep disorders (9.3%, a lower rate than the
variation in the literature of 27.4%–41.0%)3,6,10 were the
hird most common among the minor problems. There were
ore complaints of excessive sleep in relation to insomnia.
he peripheral neuropathies reported by the patients, in
ost cases tingling sensations and lack of strength in the
ppendicular skeleton, accounted for 8.1% of NC, within
he range of 2.0%–30.0%.6,9,10 Finally, headache, the least
ommon minor CN, represented 5.8%, a lower value than
reviously described reports of 18.0% and 22.7%.8,10 Minor
C were much more common (85.9%) in the early period.
lready in the late period, 79 patients (39.1%) displayed
omplications, being 80 cases (14.9% were classified as
ajor). Again, like the early period and different from the
mmediate, the majority (85%) of NC occurred among the
Fig 1. Cumulative proportional
survival curve (Kaplan-Meier) of
patients according to time (day)
of NC: immediate (1–30 days),
early (31–180 days), and late
(180 days).inor problems.In relation to patient survival, we used the Kaplan-Meier
ctuarial method (chi-square 6.35; df  2; P  .05) and the
log-rank test. Note that the sooner the NC appeared, the
greater the mortality. Thus, patients who had NC between
the first and sixth month after transplantation showed a
lower survival than those after 6 months.
In conclusion, NC among transplant recipients led to
longer hospital stays with higher and more rapid morbidity
and mortality rates. Knowledge of these complications
appears to be extremely important for the multidisciplinary
transplantation team to decrease their prevalence and
achieve early diagnosis and treatment.
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